XERS (NASDAQ) - Dividend History and Outstanding Shares

No Dividends discovered - So far (until April 2024) XERS does not pay dividends. Outstanding Shares evolving.

No Dividends
As of April 2024, Xeris Pharmaceuticals (XERS) does not pay a dividend.

Outstanding Shares

What is the Trend of XERS`s Outstanding Shares?

The Outstanding Shares of Xeris Pharmaceuticals are growing at a rate of 48.77% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 92.86%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Xeris Pharmaceuticals ever had a Stock Split?

Yes, last Stock Split was on 2021-10-06 with a factor of 1:1. This reverse stock split decreased the number of shares and increased the price per share by a ratio of 1.

Year Number of Shares (Mill.) Growth
2023 138.12 +1.57%
2022 135.99 +11.52%
2021 121.94 +127.9%
2020 53.51 +98.16%
2019 27 +29.97%
2018 20.77 +906.23%
2017 2.06 -64.14%
2016 5.76

Dividend Yields, Growth & Consistency

Overall Dividend Rating -
Dividends Paid 12m - Yield 12m -
Dividends Paid Average 5y - Yield Average 5y -
Growth Rate 5y - Yield on Cost 5y -
Payout Consistency - First Payout -
Compare XERS Dividends with its Industry Peers

No Dividends Paid


  • XERS`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price.
  • 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by price 5 years ago).
  • The 0.0% Payout Consistency of XERS Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
  • The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases XERS`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to +10.
Ratings surpassing 5 are regarded as favorable, while those exceeding 7.5 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.